Billing and Coding: Rituximab

This policy (A56380) provides billing and coding guidelines for rituximab and is intended to complement Local Coverage Determination L35026. It does not itself state clinical indications, limitations, or frequency limits; providers should follow LCD L35026 for coverage and medical necessity criteria.

"This article contains billing and coding guidelines only and does not specify clinical indications, contraindications, or coverage decisions for rituximab."

Sign up to see full coverage criteria, indications, and limitations.